Messenger RNA (mRNA) already exists in your body. It carries a “message” - instructions that direct your cells what to do. mRNA medicines fight diseases in a different way than traditional …

Moderna, Inc. (/ məˈdɜːrnə / mə-DUR-nə) [4] is an American pharmaceutical and biotechnology company based in Cambridge, Massachusetts, that focuses on RNA therapeutics, primarily …

Jan 21, 2025 · Moderna received a $590 million award from the U.S. government to speed development of a vaccine that could be used to fight bird flu. The biotech firm's mRNA-1018 …

We’re making biotech history. Since 2010, we have worked to build the industry's leading mRNA technology platform. Learn more about Moderna’s history.

4 days ago · Moderna, Inc. is a biotechnology company specializing in messenger RNA (mRNA) medicines and is best known for developing one of the first COVID-19 vaccines authorized for …

Mar 25, 2024 · Moderna is a Cambridge, MA based biotech company that made a name for itself in 2020 upon releasing one of the first COVID-19 vaccines approved for emergency use by the …

Jan 20, 2025 · Moderna is set to receive $590m in funding from the HHS to expedite the development of mRNA-based pandemic influenza vaccines.

Mar 26, 2024 · Moderna's mRNA platform has enabled the development of therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases and autoimmune diseases.

Our platform enables rapid design, research and testing of multiple mRNAs, within days. Our production methods allow us to get medicines to more people, faster. It normally takes 2–3 …

Mar 7, 2022 · Moderna announces commitment to advance vaccines targeting 15 pathogens identified as biggest public health risk by WHO and CEPI into clinical studies by 2025.